key: cord-0060595-uaejbpj5
authors: Cienfuegos, Javier A.; Almeida, Ana; Aliseda, Daniel; Rotellar, Fernando
title: Pathogenesis of pneumoperitoneum in a COVID-19 patients()
date: 2021-03-24
journal: Cir Esp (Engl Ed)
DOI: 10.1016/j.cireng.2021.03.012
sha: e9a80d8ba713c1c45c974b00f88be740fc53d6d5
doc_id: 60595
cord_uid: uaejbpj5

nan

In patients with coronavirus 2019 (COVID-19), intestinal pneumatosis and pneumoperitoneum have occasionally been described without observed intestinal perforation. [2] [3] [4] In these case, the etiopathogenic cause has been related with direct damage to the intestinal mucosa by SARS-CoV-2 -the intestinal epithelium has abundant receptors for angiotensin converting enzyme-2 (ACE-2)-and to ischemic mechanisms secondary to arterial and venous splanchnic thrombosis. 5, 6 One of the most striking phenomena in COVID-19 patients are thromboembolic complications at multiple levels, secondary to the severe systemic inflammatory response induced by SARS-CoV-2. 7,8 Therefore, antithrombotic prophylaxis is recommended in most patients with moderate or severe COVID-19. 9,10 Although the case described by Gemio del Rey et al 1 does not report the progression of fibrinogen or D-dimer levels, we feel that this etiopathogenic possibility should be considered in COVID-19 patients. 

Non-surgical Spontaneous Pneumoperitoneum in a COVID-19 Positive Patient With Severe Bilateral Pneumonia

Extensive pneumatosis intestinalis and portal venous gas mimicking mesenteric ischaemia in a patient with SARS-CoV-2

Gálvez López R. Spontaneous pneumoperitoneum and pneumatosis intestinalis as sole manifestations of a COVID-19 infection. An extremely rare complication

Abdominal imaging findings in patients with SARS-CoV-2 infection: a scoping review

COVID-19, coronavirus, SARS-CoV-2 and the small bowel

Evidence for Gastrointestinal Infection of SARS-CoV-2

Immunothrombotic dysregulation in COVID-19 pneumonia is associated with respiratory failure and coagulopathy

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up